IsoPlexis: Jason Myers

IsoPlexis has appointed biochemist and biotechnology innovator Jason Myersto its board of directors. Myers is the CEO of GenapSys. He was previously a board member of Invitae, and was cofounder, CEO, and a director of ArcherDx from 2015 to 2020.